Pricing Log in Create free account

Sotera Health Company (SHC) vs Veracyte, Inc. (VCYT)

Sotera Health Company and Veracyte, Inc. are both Diagnostics & Research companies. Sotera Health Company is the larger, with a market value of $4.5B against $1.9B — 2.3× the size. Veracyte, Inc. trades at the lower P/E: 15.2× against 26.3×. Veracyte, Inc. grew revenue faster over the last twelve months: 17.5% against 6.90%. Veracyte, Inc. has the higher net margin (21.8% vs 14.1%) and the lower return on invested capital (4.33% vs 9.80%). Across the 21 metrics below, Veracyte, Inc. leads on 18 and Sotera Health Company on 3.

Valuation

Metric SHC VCYT Diagnostics & Research median
P/E 26.27 15.16 34.52
P/S 3.69 3.34 4.24
P/B 6.19 1.35 3.42
Price to free cash flow 33.51 11.98 33.51
EV/EBITDA 11.86 11.76 23.44
EV/Sales 5.18 2.51 5.18
Earnings yield 3.81% 6.59% (1.50%)
Free cash flow yield 2.98% 8.34% 0.00%

Profitability

Metric SHC VCYT Diagnostics & Research median
Gross margin 54.62% 71.98% 48.32%
Operating margin 32.66% 17.08% (5.68%)
Net margin 14.11% 21.80% (4.10%)
Free cash flow margin 11.01% 27.84% 0.00%
Return on equity 27.03% 9.43% 0.00%
Return on assets 5.28% 8.63% (6.05%)
Return on invested capital 9.80% 4.33% 0.00%

Growth

Metric SHC VCYT Diagnostics & Research median
Revenue growth (TTM) 6.90% 17.50% 8.99%
EPS growth (last fiscal year) 68.75% 164.52% 20.36%
Revenue growth, 5-year CAGR 7.30% 34.50% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SHC VCYT Diagnostics & Research median
Debt to equity 3.06 0.00 0.01
Current ratio 3.13 5.56 2.27
Net debt to EBITDA 3.74 (5.44) 0.68

Dividend

Metric SHC VCYT Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric SHC VCYT Diagnostics & Research median
Market cap 4.53b 1.93b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack